PubMed:1002701
Annnotations
GlyCosmos6-Glycan-Motif-Image
| Id | Subject | Object | Predicate | Lexical cue | image |
|---|---|---|---|---|---|
| T1 | 90-93 | Glycan_Motif | denotes | GM1 | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G48558GR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G46613JI |
| T3 | 243-246 | Glycan_Motif | denotes | GM1 | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G48558GR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G46613JI |
| T5 | 552-555 | Glycan_Motif | denotes | GM3 | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G91237TK|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G56516VH |
| T7 | 691-694 | Glycan_Motif | denotes | GM2 | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G79389NT|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G61168WC |
| T9 | 764-767 | Glycan_Motif | denotes | GM1 | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G48558GR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G46613JI |
| T11 | 946-949 | Glycan_Motif | denotes | GM2 | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G79389NT|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G61168WC |
| T13 | 1029-1032 | Glycan_Motif | denotes | GM1 | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G48558GR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G46613JI |
| T15 | 1060-1069 | Glycan_Motif | denotes | sulfatide | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G95090DW|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G72548RZ|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G40843KY |
| T18 | 1215-1218 | Glycan_Motif | denotes | GM1 | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G48558GR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G46613JI |
| T20 | 1252-1255 | Glycan_Motif | denotes | GM1 | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G48558GR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G46613JI |
| T22 | 1441-1444 | Glycan_Motif | denotes | GM1 | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G48558GR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G46613JI |
| T24 | 1826-1829 | Glycan_Motif | denotes | GM1 | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G48558GR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G46613JI |
| T26 | 1948-1951 | Glycan_Motif | denotes | GM1 | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G48558GR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G46613JI |
| T28 | 2129-2132 | Glycan_Motif | denotes | GM1 | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G48558GR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G46613JI |
| T30 | 2247-2250 | Glycan_Motif | denotes | GM1 | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G48558GR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G46613JI |
| T32 | 2370-2373 | Glycan_Motif | denotes | GM1 | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G48558GR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G46613JI |
| T34 | 2567-2570 | Glycan_Motif | denotes | GM1 | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G48558GR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G46613JI |
| T36 | 2745-2748 | Glycan_Motif | denotes | GM1 | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G48558GR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G46613JI |
| T38 | 2861-2864 | Glycan_Motif | denotes | GM1 | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G48558GR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G46613JI |
| T40 | 2958-2961 | Glycan_Motif | denotes | GM1 | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G48558GR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G46613JI |
| T42 | 3081-3084 | Glycan_Motif | denotes | GM1 | https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G48558GR|https://api.glycosmos.org/wurcs2image/0.10.0/png/binary/G46613JI |
sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-47 | Sentence | denotes | Lipolytic action of cholera toxin on fat cells. |
| T2 | 48-138 | Sentence | denotes | Re-examination of the concept implicating GM1 ganglioside as the native membrane receptor. |
| T3 | 139-343 | Sentence | denotes | The possible role of galactosyl-N-acetylgalactosaminyl-[N-acetylneuraminyl]-galactosylglucosylceramide (GM1) ganglioside in the lipolytic activity of cholera toxin on isolated fat cells has been examined. |
| T4 | 344-756 | Sentence | denotes | Analyses of the ganglioside content and composition of intact fat cells, their membranous ghosts, and the total particulate fraction of these cells indicate that N-acetylneuraminylgalactosylglucosylceramide (GM3) represents the major ganglioside, with substantial amounts of N-acetylgalactosaminyl-[N-acetylneuraminyl]-galactosylglucosylceramide (GM2) and smaller amounts of other higher homologues also present. |
| T5 | 757-814 | Sentence | denotes | Native GM1 was not detected in any of these preparations. |
| T6 | 815-1033 | Sentence | denotes | Examination of the relative capacities of various exogenously added radiolabeled sphingolipids to bind to the cells indicated that GM2 and glucosylsphingosine were accumulated by the cells to extents comparable to GM1. |
| T7 | 1034-1148 | Sentence | denotes | Galactosylsphingosine and sulfatide also exhibited significant, although lesser, binding affinities for the cells. |
| T8 | 1149-1398 | Sentence | denotes | The adipocytes appeared to nonspecifically bind exogenously added GM1; saturation of binding sites for GM1 could not be observed up to the highest concentration tested (2 X 10(-4) M), wherein about 7 X 10(9) molecules were associated with the cells. |
| T9 | 1399-1501 | Sentence | denotes | Essentially all of this exogenously added GM1 was found bound to the plasma membrane "ghost" fraction. |
| T10 | 1502-1709 | Sentence | denotes | Investigation of the biological responses of the cells confirmed their sensitivities to both cholera toxin and epinephrine-stimulated lipolysis, as well as the lag period displayed during the toxin's action. |
| T11 | 1710-1928 | Sentence | denotes | While we could confirm that the toxin's lipolytic activity can be enhanced by prior treatment of the fat cells with GM1, several of the observed characteristics of this phenomenon differ from earlier reported findings. |
| T12 | 1929-2082 | Sentence | denotes | Accordingly, added GM1 was able to enhance only the subsequent rate, but not the extent, of toxin-stimulated glycerol release (lipolysis) from the cells. |
| T13 | 2083-2217 | Sentence | denotes | We also were unable to confirm the ability of GM1 to enhance the toxin's activity at either saturating or at low toxin concentrations. |
| T14 | 2218-2337 | Sentence | denotes | The limited ability of added GM1 to enhance the toxin's activity appeared in a unique bell-shaped dose-response manner. |
| T15 | 2338-2592 | Sentence | denotes | The inability of high levels of GM1 to stimulate a dose of toxin that was ineffective on native cells suggests that the earlier reported ability of crude brain gangliosides to accomplish this was due to some component other than GM1 in the crude extract. |
| T16 | 2593-2865 | Sentence | denotes | While several glycosphingolipids and some other carbohydrate-containing substances that were tested lacked the ability to mimic the enhancing effect of GM1, 4-methylumbelliferyl-beta-D-galactoside exhibited an effect similar to, although less pronounced than, that of GM1. |
| T17 | 2866-3208 | Sentence | denotes | The findings in these studies are unable to lend support to the earlier hypothesis that (a) GM1 is cholera toxin's naturally occurring membrane receptor on native fat cells, and (b) the ability of exogenously added GM1 to enhance the toxin's lipolytic activity represents the specific creation of additional natural receptors on adipocytes... |
| T1 | 0-47 | Sentence | denotes | Lipolytic action of cholera toxin on fat cells. |
| T2 | 48-138 | Sentence | denotes | Re-examination of the concept implicating GM1 ganglioside as the native membrane receptor. |
| T3 | 139-343 | Sentence | denotes | The possible role of galactosyl-N-acetylgalactosaminyl-[N-acetylneuraminyl]-galactosylglucosylceramide (GM1) ganglioside in the lipolytic activity of cholera toxin on isolated fat cells has been examined. |
| T4 | 344-756 | Sentence | denotes | Analyses of the ganglioside content and composition of intact fat cells, their membranous ghosts, and the total particulate fraction of these cells indicate that N-acetylneuraminylgalactosylglucosylceramide (GM3) represents the major ganglioside, with substantial amounts of N-acetylgalactosaminyl-[N-acetylneuraminyl]-galactosylglucosylceramide (GM2) and smaller amounts of other higher homologues also present. |
| T5 | 757-814 | Sentence | denotes | Native GM1 was not detected in any of these preparations. |
| T6 | 815-1033 | Sentence | denotes | Examination of the relative capacities of various exogenously added radiolabeled sphingolipids to bind to the cells indicated that GM2 and glucosylsphingosine were accumulated by the cells to extents comparable to GM1. |
| T7 | 1034-1148 | Sentence | denotes | Galactosylsphingosine and sulfatide also exhibited significant, although lesser, binding affinities for the cells. |
| T8 | 1149-1398 | Sentence | denotes | The adipocytes appeared to nonspecifically bind exogenously added GM1; saturation of binding sites for GM1 could not be observed up to the highest concentration tested (2 X 10(-4) M), wherein about 7 X 10(9) molecules were associated with the cells. |
| T9 | 1399-1501 | Sentence | denotes | Essentially all of this exogenously added GM1 was found bound to the plasma membrane "ghost" fraction. |
| T10 | 1502-1709 | Sentence | denotes | Investigation of the biological responses of the cells confirmed their sensitivities to both cholera toxin and epinephrine-stimulated lipolysis, as well as the lag period displayed during the toxin's action. |
| T11 | 1710-1928 | Sentence | denotes | While we could confirm that the toxin's lipolytic activity can be enhanced by prior treatment of the fat cells with GM1, several of the observed characteristics of this phenomenon differ from earlier reported findings. |
| T12 | 1929-2082 | Sentence | denotes | Accordingly, added GM1 was able to enhance only the subsequent rate, but not the extent, of toxin-stimulated glycerol release (lipolysis) from the cells. |
| T13 | 2083-2217 | Sentence | denotes | We also were unable to confirm the ability of GM1 to enhance the toxin's activity at either saturating or at low toxin concentrations. |
| T14 | 2218-2337 | Sentence | denotes | The limited ability of added GM1 to enhance the toxin's activity appeared in a unique bell-shaped dose-response manner. |
| T15 | 2338-2592 | Sentence | denotes | The inability of high levels of GM1 to stimulate a dose of toxin that was ineffective on native cells suggests that the earlier reported ability of crude brain gangliosides to accomplish this was due to some component other than GM1 in the crude extract. |
| T16 | 2593-2865 | Sentence | denotes | While several glycosphingolipids and some other carbohydrate-containing substances that were tested lacked the ability to mimic the enhancing effect of GM1, 4-methylumbelliferyl-beta-D-galactoside exhibited an effect similar to, although less pronounced than, that of GM1. |
| T17 | 2866-3208 | Sentence | denotes | The findings in these studies are unable to lend support to the earlier hypothesis that (a) GM1 is cholera toxin's naturally occurring membrane receptor on native fat cells, and (b) the ability of exogenously added GM1 to enhance the toxin's lipolytic activity represents the specific creation of additional natural receptors on adipocytes... |
GlyCosmos6-Glycan-Motif-Structure
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 90-93 | https://glytoucan.org/Structures/Glycans/G46613JI | denotes | GM1 |
| T2 | 90-93 | https://glytoucan.org/Structures/Glycans/G48558GR | denotes | GM1 |
| T3 | 243-246 | https://glytoucan.org/Structures/Glycans/G46613JI | denotes | GM1 |
| T4 | 243-246 | https://glytoucan.org/Structures/Glycans/G48558GR | denotes | GM1 |
| T5 | 552-555 | https://glytoucan.org/Structures/Glycans/G56516VH | denotes | GM3 |
| T6 | 552-555 | https://glytoucan.org/Structures/Glycans/G91237TK | denotes | GM3 |
| T7 | 691-694 | https://glytoucan.org/Structures/Glycans/G61168WC | denotes | GM2 |
| T8 | 691-694 | https://glytoucan.org/Structures/Glycans/G79389NT | denotes | GM2 |
| T9 | 764-767 | https://glytoucan.org/Structures/Glycans/G46613JI | denotes | GM1 |
| T10 | 764-767 | https://glytoucan.org/Structures/Glycans/G48558GR | denotes | GM1 |
| T11 | 946-949 | https://glytoucan.org/Structures/Glycans/G61168WC | denotes | GM2 |
| T12 | 946-949 | https://glytoucan.org/Structures/Glycans/G79389NT | denotes | GM2 |
| T13 | 1029-1032 | https://glytoucan.org/Structures/Glycans/G46613JI | denotes | GM1 |
| T14 | 1029-1032 | https://glytoucan.org/Structures/Glycans/G48558GR | denotes | GM1 |
| T15 | 1060-1069 | https://glytoucan.org/Structures/Glycans/G40843KY | denotes | sulfatide |
| T16 | 1060-1069 | https://glytoucan.org/Structures/Glycans/G72548RZ | denotes | sulfatide |
| T17 | 1060-1069 | https://glytoucan.org/Structures/Glycans/G95090DW | denotes | sulfatide |
| T18 | 1215-1218 | https://glytoucan.org/Structures/Glycans/G46613JI | denotes | GM1 |
| T19 | 1215-1218 | https://glytoucan.org/Structures/Glycans/G48558GR | denotes | GM1 |
| T20 | 1252-1255 | https://glytoucan.org/Structures/Glycans/G46613JI | denotes | GM1 |
| T21 | 1252-1255 | https://glytoucan.org/Structures/Glycans/G48558GR | denotes | GM1 |
| T22 | 1441-1444 | https://glytoucan.org/Structures/Glycans/G46613JI | denotes | GM1 |
| T23 | 1441-1444 | https://glytoucan.org/Structures/Glycans/G48558GR | denotes | GM1 |
| T24 | 1826-1829 | https://glytoucan.org/Structures/Glycans/G46613JI | denotes | GM1 |
| T25 | 1826-1829 | https://glytoucan.org/Structures/Glycans/G48558GR | denotes | GM1 |
| T26 | 1948-1951 | https://glytoucan.org/Structures/Glycans/G46613JI | denotes | GM1 |
| T27 | 1948-1951 | https://glytoucan.org/Structures/Glycans/G48558GR | denotes | GM1 |
| T28 | 2129-2132 | https://glytoucan.org/Structures/Glycans/G46613JI | denotes | GM1 |
| T29 | 2129-2132 | https://glytoucan.org/Structures/Glycans/G48558GR | denotes | GM1 |
| T30 | 2247-2250 | https://glytoucan.org/Structures/Glycans/G46613JI | denotes | GM1 |
| T31 | 2247-2250 | https://glytoucan.org/Structures/Glycans/G48558GR | denotes | GM1 |
| T32 | 2370-2373 | https://glytoucan.org/Structures/Glycans/G46613JI | denotes | GM1 |
| T33 | 2370-2373 | https://glytoucan.org/Structures/Glycans/G48558GR | denotes | GM1 |
| T34 | 2567-2570 | https://glytoucan.org/Structures/Glycans/G46613JI | denotes | GM1 |
| T35 | 2567-2570 | https://glytoucan.org/Structures/Glycans/G48558GR | denotes | GM1 |
| T36 | 2745-2748 | https://glytoucan.org/Structures/Glycans/G46613JI | denotes | GM1 |
| T37 | 2745-2748 | https://glytoucan.org/Structures/Glycans/G48558GR | denotes | GM1 |
| T38 | 2861-2864 | https://glytoucan.org/Structures/Glycans/G46613JI | denotes | GM1 |
| T39 | 2861-2864 | https://glytoucan.org/Structures/Glycans/G48558GR | denotes | GM1 |
| T40 | 2958-2961 | https://glytoucan.org/Structures/Glycans/G46613JI | denotes | GM1 |
| T41 | 2958-2961 | https://glytoucan.org/Structures/Glycans/G48558GR | denotes | GM1 |
| T42 | 3081-3084 | https://glytoucan.org/Structures/Glycans/G46613JI | denotes | GM1 |
| T43 | 3081-3084 | https://glytoucan.org/Structures/Glycans/G48558GR | denotes | GM1 |
Glycosmos6-MAT
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 2492-2497 | http://purl.obolibrary.org/obo/MAT_0000098 | denotes | brain |
Glycosmos6-GlycoEpitope
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 90-93 | http://www.glycoepitope.jp/epitopes/EP0050 | denotes | GM1 |
| T2 | 243-246 | http://www.glycoepitope.jp/epitopes/EP0050 | denotes | GM1 |
| T3 | 764-767 | http://www.glycoepitope.jp/epitopes/EP0050 | denotes | GM1 |
| T4 | 1029-1032 | http://www.glycoepitope.jp/epitopes/EP0050 | denotes | GM1 |
| T5 | 1215-1218 | http://www.glycoepitope.jp/epitopes/EP0050 | denotes | GM1 |
| T6 | 1252-1255 | http://www.glycoepitope.jp/epitopes/EP0050 | denotes | GM1 |
| T7 | 1441-1444 | http://www.glycoepitope.jp/epitopes/EP0050 | denotes | GM1 |
| T8 | 1826-1829 | http://www.glycoepitope.jp/epitopes/EP0050 | denotes | GM1 |
| T9 | 1948-1951 | http://www.glycoepitope.jp/epitopes/EP0050 | denotes | GM1 |
| T10 | 2129-2132 | http://www.glycoepitope.jp/epitopes/EP0050 | denotes | GM1 |
| T11 | 2247-2250 | http://www.glycoepitope.jp/epitopes/EP0050 | denotes | GM1 |
| T12 | 2370-2373 | http://www.glycoepitope.jp/epitopes/EP0050 | denotes | GM1 |
| T13 | 2567-2570 | http://www.glycoepitope.jp/epitopes/EP0050 | denotes | GM1 |
| T14 | 2745-2748 | http://www.glycoepitope.jp/epitopes/EP0050 | denotes | GM1 |
| T15 | 2861-2864 | http://www.glycoepitope.jp/epitopes/EP0050 | denotes | GM1 |
| T16 | 2958-2961 | http://www.glycoepitope.jp/epitopes/EP0050 | denotes | GM1 |
| T17 | 3081-3084 | http://www.glycoepitope.jp/epitopes/EP0050 | denotes | GM1 |
mondo_disease
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 20-27 | Disease | denotes | cholera | http://purl.obolibrary.org/obo/MONDO_0015766 |
| T2 | 289-296 | Disease | denotes | cholera | http://purl.obolibrary.org/obo/MONDO_0015766 |
| T3 | 1595-1602 | Disease | denotes | cholera | http://purl.obolibrary.org/obo/MONDO_0015766 |
| T4 | 2954-2961 | Disease | denotes | (a) GM1 | http://purl.obolibrary.org/obo/MONDO_0020729 |
| T5 | 2965-2972 | Disease | denotes | cholera | http://purl.obolibrary.org/obo/MONDO_0015766 |
Glycan-GlyCosmos
| Id | Subject | Object | Predicate | Lexical cue | image |
|---|---|---|---|---|---|
| T1 | 90-93 | Glycan | denotes | GM1 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR |
| T2 | 243-246 | Glycan | denotes | GM1 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR |
| T3 | 552-555 | Glycan | denotes | GM3 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G91237TK |
| T4 | 691-694 | Glycan | denotes | GM2 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G79389NT |
| T5 | 764-767 | Glycan | denotes | GM1 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR |
| T6 | 946-949 | Glycan | denotes | GM2 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G79389NT |
| T7 | 1029-1032 | Glycan | denotes | GM1 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR |
| T8 | 1215-1218 | Glycan | denotes | GM1 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR |
| T9 | 1252-1255 | Glycan | denotes | GM1 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR |
| T10 | 1441-1444 | Glycan | denotes | GM1 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR |
| T11 | 1826-1829 | Glycan | denotes | GM1 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR |
| T12 | 1948-1951 | Glycan | denotes | GM1 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR |
| T13 | 2129-2132 | Glycan | denotes | GM1 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR |
| T14 | 2247-2250 | Glycan | denotes | GM1 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR |
| T15 | 2370-2373 | Glycan | denotes | GM1 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR |
| T16 | 2567-2570 | Glycan | denotes | GM1 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR |
| T17 | 2745-2748 | Glycan | denotes | GM1 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR |
| T18 | 2861-2864 | Glycan | denotes | GM1 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR |
| T19 | 2958-2961 | Glycan | denotes | GM1 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR |
| T20 | 3081-3084 | Glycan | denotes | GM1 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR |
GlyCosmos15-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T1 | 20-27 | Disease | denotes | cholera | http://purl.obolibrary.org/obo/MONDO_0015766 |
| T2 | 289-296 | Disease | denotes | cholera | http://purl.obolibrary.org/obo/MONDO_0015766 |
| T3 | 1595-1602 | Disease | denotes | cholera | http://purl.obolibrary.org/obo/MONDO_0015766 |
| T4 | 2954-2961 | Disease | denotes | (a) GM1 | http://purl.obolibrary.org/obo/MONDO_0020729 |
| T5 | 2965-2972 | Disease | denotes | cholera | http://purl.obolibrary.org/obo/MONDO_0015766 |
GlyCosmos15-CL
| Id | Subject | Object | Predicate | Lexical cue | cl_id |
|---|---|---|---|---|---|
| T1 | 37-46 | Cell | denotes | fat cells | http://purl.obolibrary.org/obo/CL:0000136 |
| T2 | 315-324 | Cell | denotes | fat cells | http://purl.obolibrary.org/obo/CL:0000136 |
| T3 | 406-415 | Cell | denotes | fat cells | http://purl.obolibrary.org/obo/CL:0000136 |
| T4 | 1153-1163 | Cell | denotes | adipocytes | http://purl.obolibrary.org/obo/CL:0000136 |
| T5 | 1811-1820 | Cell | denotes | fat cells | http://purl.obolibrary.org/obo/CL:0000136 |
| T6 | 3029-3038 | Cell | denotes | fat cells | http://purl.obolibrary.org/obo/CL:0000136 |
| T7 | 3195-3205 | Cell | denotes | adipocytes | http://purl.obolibrary.org/obo/CL:0000136 |
GlyCosmos15-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T1 | 37-46 | Body_part | denotes | fat cells | http://purl.obolibrary.org/obo/CL_0000136 |
| T2 | 120-128 | Body_part | denotes | membrane | http://purl.obolibrary.org/obo/GO_0016020|http://purl.obolibrary.org/obo/UBERON_0000094|http://purl.obolibrary.org/obo/UBERON_0000158 |
| T5 | 315-324 | Body_part | denotes | fat cells | http://purl.obolibrary.org/obo/CL_0000136 |
| T6 | 406-415 | Body_part | denotes | fat cells | http://purl.obolibrary.org/obo/CL_0000136 |
| T7 | 1153-1163 | Body_part | denotes | adipocytes | http://purl.obolibrary.org/obo/CL_0000136 |
| T8 | 1468-1483 | Body_part | denotes | plasma membrane | http://purl.obolibrary.org/obo/GO_0005886 |
| T9 | 1811-1820 | Body_part | denotes | fat cells | http://purl.obolibrary.org/obo/CL_0000136 |
| T10 | 2492-2497 | Body_part | denotes | brain | http://purl.obolibrary.org/obo/UBERON_0000955|http://purl.obolibrary.org/obo/UBERON_6110636 |
| T12 | 3001-3009 | Body_part | denotes | membrane | http://purl.obolibrary.org/obo/GO_0016020|http://purl.obolibrary.org/obo/UBERON_0000094|http://purl.obolibrary.org/obo/UBERON_0000158 |
| T15 | 3029-3038 | Body_part | denotes | fat cells | http://purl.obolibrary.org/obo/CL_0000136 |
| T16 | 3195-3205 | Body_part | denotes | adipocytes | http://purl.obolibrary.org/obo/CL_0000136 |
GlyCosmos15-MAT
| Id | Subject | Object | Predicate | Lexical cue | mat_id |
|---|---|---|---|---|---|
| T1 | 2492-2497 | Body_part | denotes | brain | http://purl.obolibrary.org/obo/MAT_0000098 |
sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-47 | Sentence | denotes | Lipolytic action of cholera toxin on fat cells. |
| T2 | 48-138 | Sentence | denotes | Re-examination of the concept implicating GM1 ganglioside as the native membrane receptor. |
| T3 | 139-343 | Sentence | denotes | The possible role of galactosyl-N-acetylgalactosaminyl-[N-acetylneuraminyl]-galactosylglucosylceramide (GM1) ganglioside in the lipolytic activity of cholera toxin on isolated fat cells has been examined. |
| T4 | 344-756 | Sentence | denotes | Analyses of the ganglioside content and composition of intact fat cells, their membranous ghosts, and the total particulate fraction of these cells indicate that N-acetylneuraminylgalactosylglucosylceramide (GM3) represents the major ganglioside, with substantial amounts of N-acetylgalactosaminyl-[N-acetylneuraminyl]-galactosylglucosylceramide (GM2) and smaller amounts of other higher homologues also present. |
| T5 | 757-814 | Sentence | denotes | Native GM1 was not detected in any of these preparations. |
| T6 | 815-1033 | Sentence | denotes | Examination of the relative capacities of various exogenously added radiolabeled sphingolipids to bind to the cells indicated that GM2 and glucosylsphingosine were accumulated by the cells to extents comparable to GM1. |
| T7 | 1034-1148 | Sentence | denotes | Galactosylsphingosine and sulfatide also exhibited significant, although lesser, binding affinities for the cells. |
| T8 | 1149-1398 | Sentence | denotes | The adipocytes appeared to nonspecifically bind exogenously added GM1; saturation of binding sites for GM1 could not be observed up to the highest concentration tested (2 X 10(-4) M), wherein about 7 X 10(9) molecules were associated with the cells. |
| T9 | 1399-1501 | Sentence | denotes | Essentially all of this exogenously added GM1 was found bound to the plasma membrane "ghost" fraction. |
| T10 | 1502-1709 | Sentence | denotes | Investigation of the biological responses of the cells confirmed their sensitivities to both cholera toxin and epinephrine-stimulated lipolysis, as well as the lag period displayed during the toxin's action. |
| T11 | 1710-1928 | Sentence | denotes | While we could confirm that the toxin's lipolytic activity can be enhanced by prior treatment of the fat cells with GM1, several of the observed characteristics of this phenomenon differ from earlier reported findings. |
| T12 | 1929-2082 | Sentence | denotes | Accordingly, added GM1 was able to enhance only the subsequent rate, but not the extent, of toxin-stimulated glycerol release (lipolysis) from the cells. |
| T13 | 2083-2217 | Sentence | denotes | We also were unable to confirm the ability of GM1 to enhance the toxin's activity at either saturating or at low toxin concentrations. |
| T14 | 2218-2337 | Sentence | denotes | The limited ability of added GM1 to enhance the toxin's activity appeared in a unique bell-shaped dose-response manner. |
| T15 | 2338-2592 | Sentence | denotes | The inability of high levels of GM1 to stimulate a dose of toxin that was ineffective on native cells suggests that the earlier reported ability of crude brain gangliosides to accomplish this was due to some component other than GM1 in the crude extract. |
| T16 | 2593-2865 | Sentence | denotes | While several glycosphingolipids and some other carbohydrate-containing substances that were tested lacked the ability to mimic the enhancing effect of GM1, 4-methylumbelliferyl-beta-D-galactoside exhibited an effect similar to, although less pronounced than, that of GM1. |
| T17 | 2866-3208 | Sentence | denotes | The findings in these studies are unable to lend support to the earlier hypothesis that (a) GM1 is cholera toxin's naturally occurring membrane receptor on native fat cells, and (b) the ability of exogenously added GM1 to enhance the toxin's lipolytic activity represents the specific creation of additional natural receptors on adipocytes... |
| T1 | 0-47 | Sentence | denotes | Lipolytic action of cholera toxin on fat cells. |
| T2 | 48-138 | Sentence | denotes | Re-examination of the concept implicating GM1 ganglioside as the native membrane receptor. |
| T3 | 139-343 | Sentence | denotes | The possible role of galactosyl-N-acetylgalactosaminyl-[N-acetylneuraminyl]-galactosylglucosylceramide (GM1) ganglioside in the lipolytic activity of cholera toxin on isolated fat cells has been examined. |
| T4 | 344-756 | Sentence | denotes | Analyses of the ganglioside content and composition of intact fat cells, their membranous ghosts, and the total particulate fraction of these cells indicate that N-acetylneuraminylgalactosylglucosylceramide (GM3) represents the major ganglioside, with substantial amounts of N-acetylgalactosaminyl-[N-acetylneuraminyl]-galactosylglucosylceramide (GM2) and smaller amounts of other higher homologues also present. |
| T5 | 757-814 | Sentence | denotes | Native GM1 was not detected in any of these preparations. |
| T6 | 815-1033 | Sentence | denotes | Examination of the relative capacities of various exogenously added radiolabeled sphingolipids to bind to the cells indicated that GM2 and glucosylsphingosine were accumulated by the cells to extents comparable to GM1. |
| T7 | 1034-1148 | Sentence | denotes | Galactosylsphingosine and sulfatide also exhibited significant, although lesser, binding affinities for the cells. |
| T8 | 1149-1398 | Sentence | denotes | The adipocytes appeared to nonspecifically bind exogenously added GM1; saturation of binding sites for GM1 could not be observed up to the highest concentration tested (2 X 10(-4) M), wherein about 7 X 10(9) molecules were associated with the cells. |
| T9 | 1399-1501 | Sentence | denotes | Essentially all of this exogenously added GM1 was found bound to the plasma membrane "ghost" fraction. |
| T10 | 1502-1709 | Sentence | denotes | Investigation of the biological responses of the cells confirmed their sensitivities to both cholera toxin and epinephrine-stimulated lipolysis, as well as the lag period displayed during the toxin's action. |
| T11 | 1710-1928 | Sentence | denotes | While we could confirm that the toxin's lipolytic activity can be enhanced by prior treatment of the fat cells with GM1, several of the observed characteristics of this phenomenon differ from earlier reported findings. |
| T12 | 1929-2082 | Sentence | denotes | Accordingly, added GM1 was able to enhance only the subsequent rate, but not the extent, of toxin-stimulated glycerol release (lipolysis) from the cells. |
| T13 | 2083-2217 | Sentence | denotes | We also were unable to confirm the ability of GM1 to enhance the toxin's activity at either saturating or at low toxin concentrations. |
| T14 | 2218-2337 | Sentence | denotes | The limited ability of added GM1 to enhance the toxin's activity appeared in a unique bell-shaped dose-response manner. |
| T15 | 2338-2592 | Sentence | denotes | The inability of high levels of GM1 to stimulate a dose of toxin that was ineffective on native cells suggests that the earlier reported ability of crude brain gangliosides to accomplish this was due to some component other than GM1 in the crude extract. |
| T16 | 2593-2865 | Sentence | denotes | While several glycosphingolipids and some other carbohydrate-containing substances that were tested lacked the ability to mimic the enhancing effect of GM1, 4-methylumbelliferyl-beta-D-galactoside exhibited an effect similar to, although less pronounced than, that of GM1. |
| T17 | 2866-3208 | Sentence | denotes | The findings in these studies are unable to lend support to the earlier hypothesis that (a) GM1 is cholera toxin's naturally occurring membrane receptor on native fat cells, and (b) the ability of exogenously added GM1 to enhance the toxin's lipolytic activity represents the specific creation of additional natural receptors on adipocytes... |
GlyCosmos15-Sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 0-47 | Sentence | denotes | Lipolytic action of cholera toxin on fat cells. |
| T2 | 48-138 | Sentence | denotes | Re-examination of the concept implicating GM1 ganglioside as the native membrane receptor. |
| T3 | 139-343 | Sentence | denotes | The possible role of galactosyl-N-acetylgalactosaminyl-[N-acetylneuraminyl]-galactosylglucosylceramide (GM1) ganglioside in the lipolytic activity of cholera toxin on isolated fat cells has been examined. |
| T4 | 344-756 | Sentence | denotes | Analyses of the ganglioside content and composition of intact fat cells, their membranous ghosts, and the total particulate fraction of these cells indicate that N-acetylneuraminylgalactosylglucosylceramide (GM3) represents the major ganglioside, with substantial amounts of N-acetylgalactosaminyl-[N-acetylneuraminyl]-galactosylglucosylceramide (GM2) and smaller amounts of other higher homologues also present. |
| T5 | 757-814 | Sentence | denotes | Native GM1 was not detected in any of these preparations. |
| T6 | 815-1033 | Sentence | denotes | Examination of the relative capacities of various exogenously added radiolabeled sphingolipids to bind to the cells indicated that GM2 and glucosylsphingosine were accumulated by the cells to extents comparable to GM1. |
| T7 | 1034-1148 | Sentence | denotes | Galactosylsphingosine and sulfatide also exhibited significant, although lesser, binding affinities for the cells. |
| T8 | 1149-1398 | Sentence | denotes | The adipocytes appeared to nonspecifically bind exogenously added GM1; saturation of binding sites for GM1 could not be observed up to the highest concentration tested (2 X 10(-4) M), wherein about 7 X 10(9) molecules were associated with the cells. |
| T9 | 1399-1501 | Sentence | denotes | Essentially all of this exogenously added GM1 was found bound to the plasma membrane "ghost" fraction. |
| T10 | 1502-1709 | Sentence | denotes | Investigation of the biological responses of the cells confirmed their sensitivities to both cholera toxin and epinephrine-stimulated lipolysis, as well as the lag period displayed during the toxin's action. |
| T11 | 1710-1928 | Sentence | denotes | While we could confirm that the toxin's lipolytic activity can be enhanced by prior treatment of the fat cells with GM1, several of the observed characteristics of this phenomenon differ from earlier reported findings. |
| T12 | 1929-2082 | Sentence | denotes | Accordingly, added GM1 was able to enhance only the subsequent rate, but not the extent, of toxin-stimulated glycerol release (lipolysis) from the cells. |
| T13 | 2083-2217 | Sentence | denotes | We also were unable to confirm the ability of GM1 to enhance the toxin's activity at either saturating or at low toxin concentrations. |
| T14 | 2218-2337 | Sentence | denotes | The limited ability of added GM1 to enhance the toxin's activity appeared in a unique bell-shaped dose-response manner. |
| T15 | 2338-2592 | Sentence | denotes | The inability of high levels of GM1 to stimulate a dose of toxin that was ineffective on native cells suggests that the earlier reported ability of crude brain gangliosides to accomplish this was due to some component other than GM1 in the crude extract. |
| T16 | 2593-2865 | Sentence | denotes | While several glycosphingolipids and some other carbohydrate-containing substances that were tested lacked the ability to mimic the enhancing effect of GM1, 4-methylumbelliferyl-beta-D-galactoside exhibited an effect similar to, although less pronounced than, that of GM1. |
| T17 | 2866-3208 | Sentence | denotes | The findings in these studies are unable to lend support to the earlier hypothesis that (a) GM1 is cholera toxin's naturally occurring membrane receptor on native fat cells, and (b) the ability of exogenously added GM1 to enhance the toxin's lipolytic activity represents the specific creation of additional natural receptors on adipocytes... |
GlyCosmos15-Glycan
| Id | Subject | Object | Predicate | Lexical cue | image |
|---|---|---|---|---|---|
| T1 | 90-93 | Glycan | denotes | GM1 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR |
| T2 | 243-246 | Glycan | denotes | GM1 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR |
| T3 | 552-555 | Glycan | denotes | GM3 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G91237TK |
| T4 | 691-694 | Glycan | denotes | GM2 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G79389NT |
| T5 | 764-767 | Glycan | denotes | GM1 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR |
| T6 | 946-949 | Glycan | denotes | GM2 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G79389NT |
| T7 | 1029-1032 | Glycan | denotes | GM1 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR |
| T8 | 1215-1218 | Glycan | denotes | GM1 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR |
| T9 | 1252-1255 | Glycan | denotes | GM1 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR |
| T10 | 1441-1444 | Glycan | denotes | GM1 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR |
| T11 | 1826-1829 | Glycan | denotes | GM1 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR |
| T12 | 1948-1951 | Glycan | denotes | GM1 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR |
| T13 | 2129-2132 | Glycan | denotes | GM1 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR |
| T14 | 2247-2250 | Glycan | denotes | GM1 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR |
| T15 | 2370-2373 | Glycan | denotes | GM1 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR |
| T16 | 2567-2570 | Glycan | denotes | GM1 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR |
| T17 | 2745-2748 | Glycan | denotes | GM1 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR |
| T18 | 2861-2864 | Glycan | denotes | GM1 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR |
| T19 | 2958-2961 | Glycan | denotes | GM1 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR |
| T20 | 3081-3084 | Glycan | denotes | GM1 | https://api.glycosmos.org/wurcs2image/latest/png/binary/G48558GR |
GlyCosmos15-GlycoEpitope
| Id | Subject | Object | Predicate | Lexical cue | glycoepitope_id |
|---|---|---|---|---|---|
| T1 | 90-93 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GM1 | http://www.glycoepitope.jp/epitopes/EP0050 |
| T2 | 243-246 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GM1 | http://www.glycoepitope.jp/epitopes/EP0050 |
| T3 | 764-767 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GM1 | http://www.glycoepitope.jp/epitopes/EP0050 |
| T4 | 1029-1032 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GM1 | http://www.glycoepitope.jp/epitopes/EP0050 |
| T5 | 1215-1218 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GM1 | http://www.glycoepitope.jp/epitopes/EP0050 |
| T6 | 1252-1255 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GM1 | http://www.glycoepitope.jp/epitopes/EP0050 |
| T7 | 1441-1444 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GM1 | http://www.glycoepitope.jp/epitopes/EP0050 |
| T8 | 1826-1829 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GM1 | http://www.glycoepitope.jp/epitopes/EP0050 |
| T9 | 1948-1951 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GM1 | http://www.glycoepitope.jp/epitopes/EP0050 |
| T10 | 2129-2132 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GM1 | http://www.glycoepitope.jp/epitopes/EP0050 |
| T11 | 2247-2250 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GM1 | http://www.glycoepitope.jp/epitopes/EP0050 |
| T12 | 2370-2373 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GM1 | http://www.glycoepitope.jp/epitopes/EP0050 |
| T13 | 2567-2570 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GM1 | http://www.glycoepitope.jp/epitopes/EP0050 |
| T14 | 2745-2748 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GM1 | http://www.glycoepitope.jp/epitopes/EP0050 |
| T15 | 2861-2864 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GM1 | http://www.glycoepitope.jp/epitopes/EP0050 |
| T16 | 2958-2961 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GM1 | http://www.glycoepitope.jp/epitopes/EP0050 |
| T17 | 3081-3084 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GM1 | http://www.glycoepitope.jp/epitopes/EP0050 |
GlyCosmos-GlycoEpitope
| Id | Subject | Object | Predicate | Lexical cue | glycoepitope_id |
|---|---|---|---|---|---|
| T1 | 90-93 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GM1 | http://www.glycoepitope.jp/epitopes/EP0050 |
| T2 | 243-246 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GM1 | http://www.glycoepitope.jp/epitopes/EP0050 |
| T3 | 764-767 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GM1 | http://www.glycoepitope.jp/epitopes/EP0050 |
| T4 | 1029-1032 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GM1 | http://www.glycoepitope.jp/epitopes/EP0050 |
| T5 | 1215-1218 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GM1 | http://www.glycoepitope.jp/epitopes/EP0050 |
| T6 | 1252-1255 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GM1 | http://www.glycoepitope.jp/epitopes/EP0050 |
| T7 | 1441-1444 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GM1 | http://www.glycoepitope.jp/epitopes/EP0050 |
| T8 | 1826-1829 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GM1 | http://www.glycoepitope.jp/epitopes/EP0050 |
| T9 | 1948-1951 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GM1 | http://www.glycoepitope.jp/epitopes/EP0050 |
| T10 | 2129-2132 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GM1 | http://www.glycoepitope.jp/epitopes/EP0050 |
| T11 | 2247-2250 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GM1 | http://www.glycoepitope.jp/epitopes/EP0050 |
| T12 | 2370-2373 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GM1 | http://www.glycoepitope.jp/epitopes/EP0050 |
| T13 | 2567-2570 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GM1 | http://www.glycoepitope.jp/epitopes/EP0050 |
| T14 | 2745-2748 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GM1 | http://www.glycoepitope.jp/epitopes/EP0050 |
| T15 | 2861-2864 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GM1 | http://www.glycoepitope.jp/epitopes/EP0050 |
| T16 | 2958-2961 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GM1 | http://www.glycoepitope.jp/epitopes/EP0050 |
| T17 | 3081-3084 | http://purl.jp/bio/12/glyco/glycan#Glycan_epitope | denotes | GM1 | http://www.glycoepitope.jp/epitopes/EP0050 |
Anatomy-MAT
| Id | Subject | Object | Predicate | Lexical cue | mat_id |
|---|---|---|---|---|---|
| T1 | 2492-2497 | Body_part | denotes | brain | http://purl.obolibrary.org/obo/MAT_0000098 |
Anatomy-UBERON
| Id | Subject | Object | Predicate | Lexical cue | uberon_id |
|---|---|---|---|---|---|
| T1 | 37-46 | Body_part | denotes | fat cells | http://purl.obolibrary.org/obo/CL_0000136 |
| T2 | 120-128 | Body_part | denotes | membrane | http://purl.obolibrary.org/obo/GO_0016020|http://purl.obolibrary.org/obo/UBERON_0000094|http://purl.obolibrary.org/obo/UBERON_0000158 |
| T5 | 315-324 | Body_part | denotes | fat cells | http://purl.obolibrary.org/obo/CL_0000136 |
| T6 | 406-415 | Body_part | denotes | fat cells | http://purl.obolibrary.org/obo/CL_0000136 |
| T7 | 1153-1163 | Body_part | denotes | adipocytes | http://purl.obolibrary.org/obo/CL_0000136 |
| T8 | 1468-1483 | Body_part | denotes | plasma membrane | http://purl.obolibrary.org/obo/GO_0005886 |
| T9 | 1811-1820 | Body_part | denotes | fat cells | http://purl.obolibrary.org/obo/CL_0000136 |
| T10 | 2492-2497 | Body_part | denotes | brain | http://purl.obolibrary.org/obo/UBERON_0000955|http://purl.obolibrary.org/obo/UBERON_6110636 |
| T12 | 3001-3009 | Body_part | denotes | membrane | http://purl.obolibrary.org/obo/GO_0016020|http://purl.obolibrary.org/obo/UBERON_0000094|http://purl.obolibrary.org/obo/UBERON_0000158 |
| T15 | 3029-3038 | Body_part | denotes | fat cells | http://purl.obolibrary.org/obo/CL_0000136 |
| T16 | 3195-3205 | Body_part | denotes | adipocytes | http://purl.obolibrary.org/obo/CL_0000136 |
CL-cell
| Id | Subject | Object | Predicate | Lexical cue | cl_id |
|---|---|---|---|---|---|
| T1 | 37-46 | Cell | denotes | fat cells | http://purl.obolibrary.org/obo/CL:0000136 |
| T2 | 315-324 | Cell | denotes | fat cells | http://purl.obolibrary.org/obo/CL:0000136 |
| T3 | 406-415 | Cell | denotes | fat cells | http://purl.obolibrary.org/obo/CL:0000136 |
| T4 | 1153-1163 | Cell | denotes | adipocytes | http://purl.obolibrary.org/obo/CL:0000136 |
| T5 | 1811-1820 | Cell | denotes | fat cells | http://purl.obolibrary.org/obo/CL:0000136 |
| T6 | 3029-3038 | Cell | denotes | fat cells | http://purl.obolibrary.org/obo/CL:0000136 |
| T7 | 3195-3205 | Cell | denotes | adipocytes | http://purl.obolibrary.org/obo/CL:0000136 |